Bdh1 and HMGCS2 mRNA and protein expression levels were significantly higher in the 2-DG-treated cachexia group than in the untreated cachexia model group, indicating that ketogenesis was activated in response to the 2-DG treatment (Figure 4F). The gene discussed is BDH1; the disease is Cachexia.